Harvard Bioscience, Inc. Share Price
Stocks
HBIO
US4169062043
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.080 USD | +1.16% |
|
+1.33% | -9.09% |
| 13/05 | Harvard Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 12/05 | Harvard Bioscience, Inc., Q1 2026 Earnings Call, May 12, 2026 |
| Market Cap | 2.74Cr 2.41Cr 2.23Cr 2.08Cr 3.9Cr 258.48Cr 3.98Cr 27Cr 10Cr 127.51Cr 10Cr 10Cr 443.61Cr | P/E 2026 * |
-3.1x | P/E 2027 * | -13.8x |
|---|---|---|---|---|---|
| Enterprise Value | 2.74Cr 2.41Cr 2.23Cr 2.08Cr 3.9Cr 258.48Cr 3.98Cr 27Cr 10Cr 127.51Cr 10Cr 10Cr 443.61Cr | EV / Sales 2026 * |
0.31x | EV / Sales 2027 * | 0.29x |
| Free-Float |
90.52% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Harvard Bioscience, Inc.
| 1 day | +1.16% | ||
| 1 week | +1.33% | ||
| Current month | +3.40% | ||
| 1 month | +8.77% | ||
| 3 months | +18.52% | ||
| 6 months | -16.18% | ||
| Current year | -9.09% |
| 1 week | 5.82 |  | 6.18 |
| 1 month | 5.26 | | 6.69 |
| Current year | 4 | | 7.5 |
| 1 year | 3.76 | | 9.4 |
| 3 years | 2.81 | | 59.95 |
| 5 years | 2.81 | | 87.5 |
| 10 years | 2.81 | | 87.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Duke
CEO | Chief Executive Officer | 55 | 28/07/2025 |
Mark Frost
DFI | Director of Finance/CFO | 63 | 12/05/2025 |
Diane Houston
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Katherine Eade
BRD | Director/Board Member | 52 | 24/10/2017 |
John Duke
BRD | Director/Board Member | 55 | 02/06/2025 |
Robert Gagnon
BRD | Director/Board Member | 52 | 16/07/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 09/06 | Free | Director | 16,556 | 0.3671% | ||
| 09/06 | Free | Director | 16,556 | 0.3671% | ||
| 09/06 | Free | Director | 16,556 | 0.3671% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.16% | +1.33% | +14.78% | -89.76% | 2.74Cr | |
| +4.87% | +6.61% | +21.72% | -6.11% | 18TCr | |
| -0.33% | -0.09% | -23.18% | +22.79% | 14TCr | |
| +5.53% | +6.25% | -4.36% | -20.70% | 13TCr | |
| -2.50% | -1.09% | -57.30% | -17.62% | 6.61TCr | |
| +3.12% | +3.44% | +18.21% | -0.75% | 5.16TCr | |
| +0.22% | -0.44% | -27.02% | -32.17% | 4.34TCr | |
| +3.92% | +5.87% | +11.89% | +10.22% | 3.72TCr | |
| +3.35% | +3.41% | +6.45% | +42.08% | 3.62TCr | |
| +1.82% | +6.10% | -9.86% | -18.72% | 2.95TCr | |
| Average | +2.56% | -0.13% | -4.87% | -11.07% | 7.23TCr | |
| Weighted average by Cap. | +3.23% | -0.60% | -4.90% | -2.61% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.86Cr 7.8Cr 7.19Cr 6.73Cr 13Cr 835.13Cr 13Cr 86Cr 33Cr 411.97Cr 33Cr 33Cr 1.43TCr | 9.42Cr 8.29Cr 7.65Cr 7.15Cr 13Cr 887.92Cr 14Cr 92Cr 36Cr 438Cr 35Cr 35Cr 1.52TCr |
| Net income | -90.5L -79.68L -73.49L -68.73L -1.29Cr -85Cr -1.31Cr -8.83Cr -3.42Cr -42Cr -3.4Cr -3.32Cr -146.4Cr | -20.5L -18.05L -16.65L -15.57L -29.17L -19Cr -29.72L -2Cr -77.49L -9.53Cr -76.97L -75.3L -33Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/26/24 | $6.080 | +1.16% | 18,782 |
| 23/26/23 | $6.010 | -0.74% | 8,972 |
| 22/26/22 | $6.055 | +3.15% | 17,957 |
| 18/26/18 | $5.870 | -2.17% | 21,012 |
| 17/26/17 | $6.000 | +0.84% | 8,473 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HBIO Stock
Select your edition
All financial news and data tailored to specific country editions
